Targeting the IL33-NLRP3 axis improves therapy for experimental cerebral malaria. (2018)

First Author: Strangward P
Attributed to:  mTOR control of effector CD4+ T cell activation during malaria infection funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1073/pnas.1801737115

PubMed Identifier: 29954866

Publication URI: http://europepmc.org/abstract/MED/29954866

Type: Journal Article/Review

Volume: 115

Parent Publication: Proceedings of the National Academy of Sciences of the United States of America

Issue: 28

ISSN: 0027-8424